SCIENTIFIC PROGRAMME
• Symposia |
• ERA-EDTA Registry Report |
| • Plenary Lecture 1 |
| Sunday, July 16 2006 – 8.00-8.45 |
Cellular
oxygen sensing in health and disease: from erythropoietin to oxygen |
Peter
Ratcliffe, Oxford, United Kingdom |
| • Plenary Lecture 2 |
| Monday, July 17 2006 – 8.00-8.45 |
Novel
roles of the renal lymphatic system in health and disease |
Dontscho
Kerjaschki, Vienna, Austria |
| • Plenary Lecture 3 |
| Tuesday, July 18 2006 – 8.00-8.45 |
| Vasoactive peptides and angiogenesis: from bench to bedside |
Pierre
Corvol, Paris, France |
| top |
| • Free Communications + Mini Lecture 1 |
| Sunday, July 16 2006 – 9.00-10.30 |
| Ischaemic pre-conditioning |
| Ischaemic pre-conditioning |
| Josep M. Grinyo, Barcelona, Spain |
| 4 free communications |
| • Free Communications + Mini Lecture 2 |
| Sunday, July 16 2006 – 9.00-10.30 |
| Genetic diseases of the kidney |
| Recent advances in the treatment of Fabry's disease |
| Dominique Germain, Paris, France |
| 4 free communications |
| • Free Communications + Mini Lecture 3 |
| Sunday, July 16 2006 – 13.45-15.15 |
| Edema and extracellular water |
| Molecular mechanisms of edema formation in nephrotic syndrome: therapeutic implications |
| Alain Doucet, Paris, France |
| 4 free communications |
| • Free Communications + Mini Lecture 4 |
| Sunday, July 16 2006 – 13.45-15.15 |
| Chronic kidney disease (CKD) |
| Scotland and renal replacement: an historical perspective |
| David Hamilton, Fife, United Kingdom |
| 4 free communications |
| • Free Communications + Mini Lecture 5 |
| Sunday, July 16 2006 – 15.45-17.15 |
| Podocytes and tubular injury |
| New tales of megalin and renal tubule disorders |
| Erik Christensen, Aarhus, Denmark |
| 4 free communications |
| • Free Communications + Mini Lecture 6 |
| Sunday, July 16 2006 – 15.45-17.15 |
| Outcome of renal transplantation |
| Changing therapies for CMV in the transplant patients |
| Anders Hartmann, Oslo, Norway |
| 4 free communications |
| • Free Communications + Mini Lecture 7 |
| Monday, July 17 2006 – 9.00-10.30 |
| Mineral metabolism: From pathophysiology to treatment |
| Pathophysiology and consequences of renal phosphate leaks |
| Dominique Prié, Paris, France |
| 4 free communications |
| • Free Communications + Mini Lecture 8 |
| Monday, July 17 2006 – 9.00-10.30 |
| Fibrosis and renoprotection |
| Renoprotection: is it blood pressure or proteinuria that matters? |
| Piero Ruggenenti, Bergamo, Italy |
| 4 free communications |
| • Free Communications + Mini Lecture 9 |
| Monday, July 17 2006 – 9.00-10.30 |
| Renal biopsy and the pathophysiology of renal injury |
| Probing oxidant injury in the renal biopsy |
| Maria Pia Rastaldi, Milan, Italy |
| 4 free communications |
| • Free Communications + Mini Lecture 10 |
| Monday, July 17 2006 – 13.45-15.15 |
| Disorders of calcium and phosphate handling: From stone to bone |
| Kidney stone and the renal tubule epithelium: a new look at nephrolithiasis and nephrocalcinosis |
| Marc de Broe, Antwerp, Belgium |
| 4 free communications |
| • Free Communications + Mini Lecture 11 |
| Monday, July 17 2006 – 15.45-17.15 |
| The juxtaglomerular apparatus and progression |
| The juxtaglomerular apparatus revisited |
| Laszlo Rosivall, Budapest, Hungary |
| 4 free communications |
| • Free Communications + Mini Lecture 12 |
| Monday, July 17 2006 – 15.45-17.15 |
| ADMA and the cardiovascular risk in renal disease |
| ADMA in renal disease |
| Danilo Fliser, Hannover, Germany |
| 4 free communications |
| • Free Communications + Mini Lecture 13 |
| Monday, July 17 2006 – 15.45-17.15 |
| New biomarkers and therapeutic strategies of cardiovascular events in the renal patient |
| New biomarkers and therapeutic strategies in the atherosclerotic patient |
| Jesus Egido, Madrid, Spain |
| 4 free communications |
| • Free Communications + Mini Lecture 14 |
| Tuesday, July 18 2006 – 9.00-10.30 |
| Physical fitness and CKD |
| Physical fitness: predictor of morbidity and mortality in patients with chronic and end-stage kidney disease |
| Naomi Clyne, Sodertalje, Sweden (for the WGRR (European Working Group on Renal Rehabilitation and Exercise Physiology) |
| 4 free communications |
| • Free Communications + Mini Lecture 15 |
| Tuesday, July 18 2006 – 9.00-10.30 |
| New treatments for acute humoral rejection and transplant outcome |
| New treatments for acute humoral rejection |
| Manuel Pascual, Lausanne, Switzerland |
| 4 free communications |
| • Free Communications + Mini Lecture 16 |
| Tuesday, July 18 2006 – 11.00-12.30 |
| Hyperparathyroidism: From pathomechanisms to treatment |
| New insights in the molecular mechanism of parathyroid hyperplasia |
| Adriana Dusso, St. Louis, USA |
| 4 free communications |
| top |
| • Symposium 1 |
| Sunday, July 16 2006 – 9.00-10.30 |
| Regression of renal fibrosis and chronic kidney disease: myth or reality? |
| - BMP-7 and the kidney |
| Michael Zeisberg, Boston, USA |
| - Inflammation and regression in nephroangiosclerosis |
| Christos Chatziantoniou, Paris, France |
| - Regression of renal disease: what is the no-return point? |
| Giuseppe Remuzzi, Bergamo, Italy |
| • Symposium 2 |
| Sunday, July 16 2006 – 9.00-10.30 |
| Vasculitis: new options beyond steroids and cytotoxic drugs |
| - ANCA-associated vasculitis: recent insights into pathophysiology |
| Caroline Savage, Birmingham, United Kingdom |
| - New therapies for vasculitis using biologics |
| Wolfgang L. Gross, Lübeck, Germany |
| - Optimisation of maintenance treatments in ANCA-associated vasculitis |
| Loïc Guillevin, Paris, France |
| • Symposium 3 |
| Sunday, July 16 2006 – 9.00-10.30 |
| Disorders of phosphate and calcium handling: from gene to therapeutic intervention |
| - Genetic aspects |
| Rajesh Thakker, Oxford, United Kingdom |
| - A genetic look at nephrolithiasis: therapeutic implications |
| Giovanni Gambaro, Verona, Italy |
| - Therapeutic approaches to hyperphosphatemia
in chronic renal failure |
| Tilman Drueke, Paris, France |
| • Symposium 4 |
| Sunday, July 16 2006 – 9.00-10.30 |
| Vascular access and bioengineering |
| - Factors involved in A-V fistula survival in incident haemodialysis patients |
| Fabio Malberti, Cremona, Italy |
| - Anastomotic strategies to improve haemodialysis access patency in non-diabetic and diabetic patients |
| Klaus Konner, Cologne, Germany |
| - Imaging of A-V fistulae and angioplasty salvage strategies |
| Luc Turmel-Rodrigues, Tours, France |
| • Symposium 5 |
| Sunday, July 16 2006 – 13.45-15.15 |
| Immunosuppressive agents and the cardiovascular risk profile after transplantation |
| - Impact of immunosuppressive agents on cardiovascular risk profile |
| Francesco Paolo Schena, Bari, Italy |
| - The role of lipids and new onset diabetes mellitus |
| Josep M. Campistol, Barcelona, Spain |
| - The contribution of CMV infection to cardiovascular complications after renal transplantation |
| Christophe Legendre, Paris, France |
| • Symposium 6 |
| Sunday, July 16 2006 – 13.45-15.15 |
| Cystic diseases of the kidney: new pathophysiological concepts and therapeutic prospects |
| - Cell polarity: a unifying concept for nephronophthisis and other cystic kidney disease? |
| Friedhelm Hildebrandt, Ann Arbor, USA |
| - Polycystic kidney disease and cilia: all or just part of the story? |
| Richard Sandford, Cambridge, United Kingdom |
| - New therapeutic options |
| Yves Pirson, Brussels, Belgium |
| • Symposium 7 |
| Sunday, July 16 2006 – 13.45-15.15 |
| The pathobiology of the peritoneal cavity: new clues to improved outcome |
| - Role of clinical and genetic factors in the permeability of the peritoneal membrane |
| Olivier Devuyst, Brussels, Belgium |
| - The immune response to peritonitis |
| Amos Douvdevani, Beer-Sheva, Israel |
| - Epithelial to mesenchymal transition of the mesothelial cell: a cause of fibrosis and angiogenesis |
| Rafael Selgas, Madrid, Spain |
| - Impact of dialysis solutions on membrane longevity |
| Andreas Fusshoeller, Düsseldorf, Germany |
| • Symposium 8 |
| Sunday, July 16 2006 – 15.45-17.15 |
| Toward the identification of novel biomarkers in the renal patient |
| - The urinary proteome: a tool to discover biomarkers of diseases? |
| Gerhard Anton Müller, Goettingen, Germany |
| - Proteomics: a tool to unravel the pathophysiology of uraemia? |
| Raymond Vanholder, Ghent, Belgium |
| - Urinary podocyte loss: a specific marker of ongoing glomerular damage |
| Jürgen Floege, Aachen, Germany |
| • Symposium 9 |
| Sunday, July 16 2006 – 15.45-17.15 |
| HIV nephropathy in the HAART era |
| - HIV and the immune response to it |
| Lucy Dorrell, Oxford, United Kingdom |
| - Pathophysiology and treatment of HIV-related nephropathies |
| J.B. Kopp, Bethesda, USA |
| - Toxicity of antiretroviral drugs and immune reconstitution syndrome: the two sides of the coin |
| Eric Daugas, Paris, France |
| • Symposium 10 |
| Sunday, July 16 2006 – 15.45-17.15 |
| Immune mechanisms of renal diseases: towards new targets for therapy |
| - Chemokines and chemokine receptors: multifunctional therapeutic targets |
| Paola Romagnani, Florence, Italy |
| - Toll-like receptors as mediators of renal disease |
| Detlef Schlöndorff, Munich, Germany |
| - Macrophages in sensing and modulating injury |
| Jeremy Hughes, Edinburgh, United Kingdom |
| • Symposium 11 |
| Sunday, July 16 2006 – 15.45-17.15 |
| News from observational studies: DOPPS and COSMOS |
| - Observational studies limitations and strenghts |
| Robert Wolfe, Ann Arbor, USA |
| - The first results from COSMOS (Current Management Of Secondary Hyperparathyroidism: a Multicentre Observational Study from 19 European countries) |
| Jorge B. Cannata-Andía, Oviedo, Spain |
| - New results from the DOPPS. Modifiable factors associated with cardio-vascular outcomes in HD patients |
| Friedrich K. Port, Ann Arbor, USA |
| - Correcting the trend for catheter use as vascular access: lessons from the DOPPS |
| Roger Greenwood, Stevenage, United Kingdom |
| • Symposium 12 |
| Monday, July 17 2006 – 9.00-10.30 |
| Stem cells: the facts, the promise and the hope |
| - Seeking stem cells of the kidney |
| Enyu Imai, Osaka, Japan |
| - Renal progenitor cells of the adult kidney |
| Giovanni Camussi, Turin, Italy |
| - Haematopoietic stem cells in renal tissue repair: the facts and the hope |
| Sandrine Florquin, Amsterdam, the Netherlands |
| - Stem cells as a new therapy to cure renal failure: myth or reality? |
| Richard Poulsom, London, United Kingdom |
| • Symposium 13 |
| Monday, July 17 2006 – 9.00-10.30 |
| Microscopic haematuria: the nephrologist's nightmare |
| - Non-Alport collagen mutations result in a spectrum of eye, brain and renal phenotypes |
| Tom Van Agtmael, Edinburgh, United Kingdom |
| - Genetic diseases of the glomerular basement membrane |
| Marie Claire Gubler, Paris, France |
| - Epidemiology and clinical investigation with emphasis on urine microscopy |
| Giovanni B. Fogazzi, Milan, Italy |
| • Symposium 14 |
| Monday, July 17 2006 – 9.00-10.30 |
| New aspects of cardiovascular disease in the renal patient (in collaboration with the Scottish Renal Association (SRA)) |
| - The impact of new cardiac imaging techniques in the renal patient |
| Alan G. Jardine, Glasgow, United Kingdom |
| - Sleep apnea: a cardiovascular risk factor in CKD |
| Francesca Mallamaci, Reggio Calabria, Italy |
| - Arterial rigidity: a new surrogate marker of cardiovascular risk |
| Gérard London, Fleury Merogis, France |
| - The influence of renal anaemia on the burden of cadiovascular disease |
| Iain C. Macdougall, London, United Kingdom |
| • Symposium 15 |
| Monday, July 17 2006 – 13.45-15.15 |
| Cancer and viral infections in transplant recipients: limiting the risk and improving the treatment |
| - Posttransplant lymphomas |
| Gerhard Opelz, Heidelberg, Germany |
| - Should Hepatitis C virus infection after renal transplantation be considered as a new surrogate marker for late graft loss? |
| José M. Morales, Madrid, Spain |
| - Kaposi sarcoma and solid tumors |
| Giuseppe Grandaliano, Bari, Italy |
| - Polyoma BK virus infection |
| Fabrizio Ginevri, Genoa, Italy |
| • Symposium 16 |
| Monday, July 17 2006 – 13.45-15.15 |
| Congenital anomalies of the kidney and urinary tract (CAKUT): still a major cause of renal failure from the paediatric agegroup to adulthood |
| - Human renal tract malformations: unravelling the genes |
| Adrian Woolf, London, United Kingdom |
| - Strategies for early diagnosis and care |
| Eric Girardin, Geneva, Switzerland |
| - Surgical care and perspectives |
| Yves Aigrain, Paris, France |
| • Symposium 17 |
| Monday, July 17 2006 – 13.45-15.15 |
| Hypertension and genetics |
| - Identification of hypertension-related genes using new genetic approaches |
| Norbert Huebner, Berlin, Germany |
| - Role of the adducin genes in human essential hypertension and in the progression of renal failure |
| Giuseppe Bianchi, Milan, Italy |
| - WNK kinases and hypertension: ion transport and beyond |
| Xavier Jeunemaitre, Paris, France |
| • Symposium 18 |
| Monday, July 17 2006 – 13.45-15.15 |
| Prospects and challenges for dialysis in Europe |
| - Transitional epidemiology and the chronic kidney disease epidemic |
| Carmine Zoccali, Reggio Calabria, Italy |
| - Managing dialysis in Europe: --Western Europe: the challenge of an “older and sicker” population |
| Francesco Locatelli, Lecco, Italy |
| --Central and Eastern Europe: the challenge of an expanding renal population with an evolving disease pattern |
| Adrian Covic, Iasi, Romania |
| • Symposium 19 |
| Monday, July 17 2006 – 15.45-17.15 |
| Late breaking trials |
| - Cardiovascular effects of lowering homocysteine in people with renal insufficiency: a large placebo controlled trial |
| Johannes Mann, Munich, Germany |
| 4 free communications |
| • Symposium 20 |
| Monday, July 17 2006 – 15.45-17.15 |
| Clinico-Pathological Conference |
| Renal biopsy - clinical correlations |
| Agnes Fogo, Nashville, USA |
| Jan Weening, Amsterdam, the Netherlands |
| Clinical discussants: |
| John Feehally, Leicester, United Kingdom |
| Jeremy Levy, London, United Kingdom |
| • Symposium 21 |
| Monday, July 17 2006 – 15.45-17.15 |
| Improving outcomes: guidelines and the reality of clinical practice |
| - KDIGO: Need and applicability of global guidelines |
| Garabed Eknoyan, Houston, USA |
| - Recommended and achieved treatment goals in CKD. The TABLE study |
| Luca De Nicola, Naples, Italy |
| - New NKF-USA KDOQI guidelines: diabetes in chronic kidney disease |
| Katherine Tuttle, Spokane, USA |
| Robert Nelson, Phoenix, USA |
| • Symposium 22 |
| Tuesday, July 18 2006 – 9.00-10.30 |
| Vascular medicine: new insights and therapeutic implications |
| - Small artery structure in human hypertension |
| Anthony M. Heagerty, Manchester, United Kingdom |
| - Innate and acquired immunity in hypertensive target organ damage |
| Dominik N. Müller, Berlin, Germany |
| - Evidence for the relevance of angiotensin II type 2 receptors in man: therapeutic consequences |
| A.H. Jan Danser, Rotterdam, the Netherlands |
| • Symposium 23 |
| Tuesday, July 18 2006 – 9.00-10.30 |
| The metabolic syndrome: a new plague of the 21st century |
| - Genes and obesity |
| Karine Clément, Paris, France |
| - The spectrum of renal abnormalities in the metabolic syndrome |
| Eberhard Ritz, Heidelberg, Germany |
| - New therapeutic approaches to obesity (Cannabinoid receptor blockers) |
| Stephan Rössner, Stockholm, Sweden |
| • Symposium 24 |
| Tuesday, July 18 2006 – 9.00-10.30 |
| The complement system and innate immunity in kidney disease |
| - A role for complement in innate immunity and autoimmunity: implications for renal disease |
| Anja Roos, Leiden, the Netherlands |
| - Complement in ischemia-reperfusion injury and transplantation |
| Steven Sacks, London, United Kingdom |
| - Complement activation and control in the kidney |
| Jürg Schifferli, Basel, Switzerland |
| • Symposium 25 |
| Tuesday, July 18 2006 – 9.00-10.30 |
| Acute renal failure: new insights and therapeutic approaches |
| - Acute renal failure in sepsis from pathophysiology to therapy |
| Claudio Ronco, Vicenza, Italy |
| - Acute kidney injury and critical illness: cause or consequence? |
| Ravindra L. Mehta, San Diego, USA |
| - Haemodynamic management of acute renal failure |
| W. van Biesen, Ghent, Belgium |
| • Symposium 26 |
| Tuesday, July 18 2006 – 11.00-12.30 |
| Tailoring immunosuppression in chronic allograft nephropathy |
| - Chronic allograft nephropathy: a new look at an old problem |
| Daniel Seron, Barcelona, Spain |
| - New markers of chronic allograft nephropathy |
| Hans-Peter Marti, Bern, Switzerland |
| - Calcineurin inhibitors: minimisation or elimination? |
| Yves Vanrenterghem, Leuven, Belgium |
| • Symposium 27 |
| Tuesday, July 18 2006 – 11.00-12.30 |
| The nephrotic syndrome revisited: the lymphocyte-podocyte connection |
| - A genetic view of nephrosis |
| Corinne Antignac, Paris, France |
| - Effects of plasma on podocytes: more questions than answers |
| Peter Mathieson, Bristol, United Kingdom |
| - T-lymphocyte alterations in relapsing minimal change disease |
| Djillali Sahali, Créteil, France |
| - Rescue therapy for steroid-resistant nephrotic syndrome |
| Rosanna Coppo, Turin, Italy |
| • Symposium 28 |
| Tuesday, July 18 2006 – 11.00-12.30 |
| Iron metabolism, erythropoietin and the kidney |
| - Anaemia of inflammation: the cytokine-hepcidin link |
| Walter H. Hörl, Vienna, Austria |
| - Iron and the kidney: the lipocalin story |
| Jonathan Barasch, New York, USA |
| - New aspects of the feedback regulation of erythropoietin |
Kai-Uwe Eckardt, Erlangen, Germany |
| “Last minute session”: recent results from clinical trials |
| top |
| • Literature Update 1 |
| Sunday, July 16 2006 – 17.30-18.15 |
| Basic science |
| Gérard Friedlander, Paris, France |
| Andrew Rees, Aberdeen, United Kingdom |
| • Literature Update 2 |
| Sunday, July 16 2006 – 17.30-18.15 |
| Glomerulonephritis |
| Daniel Cattran, Toronto, Canada |
| Loreto Gesualdo, Foggia, Italy |
| • Literature Update 3 |
| Sunday, July 16 2006 – 17.30-18.15 |
| Acute renal failure, ICU nephrology |
| Norbert Lameire, Ghent, Belgium |
| Eric Rondeau, Paris, France |
| • Literature Update 4 |
| Sunday, July 16 2006 – 17.30-18.15 |
| Transplantation |
| Charles Newstead, Leeds, United Kingdom |
| Soren Schwarz Sorensen, Copenhagen, Denmark |
| • Literature Update 5 |
| Monday, July 17 2006 – 17.30-18.15 |
| Systemic disease, vasculitis |
| David Jayne, Cambridge, United Kingdom |
| Claudio Ponticelli, Milan, Italy |
| • Literature Update 6 |
| Monday, July 17 2006 – 17.30-18.15 |
| Diabetic nephropathy and renoprotection |
| P.E. de Jong, Groningen, the Netherlands |
| Dimitrios Tsakiris, Thessaloniki, Greece |
| • Literature Update 7 |
| Monday, July 17 2006 – 17.30-18.15 |
| Hypertension and vascular disease |
| Friedrich C. Luft, Berlin, Germany |
| Ton Rabelink, Leiden, the Netherlands |
| • Literature Update 8 |
| Monday, July 17 2006 – 17.30-18.15 |
| Dialysis |
| Bernard Canaud, Montpellier, France |
| David Goldsmith, London, United Kingdom |
| top |
| • Hands-on Course 1 |
| Sunday, July 16 2006 – 10.30-12.00 |
| How to... reduce the nosocomial risk in a dialysis unit/renal transplantation centre |
| Ali Basci, Izmir, Turkey |
| Michel Jadoul, Brussels, Belgium |
| • Hands-on Course 2 |
| Sunday, July 16 2006 – 10.30-12.00 |
| How to... assess GFR/proteinuria |
| Pascal Houillier, Paris, France |
| Dick de Zeeuw, Groningen, the Netherlands |
| • Hands-on Course 3 |
| Sunday, July 16 2006 – 10.30-12.00 |
| Diagnostic techniques in the haemodialysis environment: from fluid volume status to AV fistula monitoring |
| Martin K. Kuhlmann, Berlin, Germany |
| Karel M.L. Leunissen, Maastricht, the Netherlands |
| Antonio Santoro, Bologna, Italy |
| • Hands-on Course 4 |
| Sunday, July 16 2006 – 10.30-12.00 |
| New Haemodialysis guidelines |
| Denis Fouque, Lyon, France |
| Jeroen Kooman, Maastricht, the Netherlands |
| James Tattersall, Leeds United Kingdom |
| Jan H. M. Tordoir, Maastricht, the Netherlands |
| • Hands-on Course 5 |
| Monday, July 17 2006 – 10.30-12.00 |
| How to... provide exercise training for the renal patient |
| Thomas Mercer, Bangor, United Kingdom (for the WGRR (European Working Group on Renal Rehabilitation and Exercise Physiology) |
| • Hands-on Course 6 |
| Monday, July 17 2006 – 10.30-12.00 |
| How to... review a manuscript |
| Norbert Lameire, Ghent, Belgium |
| Tilman Drueke, Paris, France |
| • Hands-on Course 7 |
| Monday, July 17 2006 – 10.30-12.00 |
| Clinical Epidemiology |
| Friedo Dekker, Leiden, the Netherlands |
| Kitty Jager, Amsterdam, the Netherlands |
| Carmine Zoccali, Reggio Calabria, Italy |
| • Hands-on Course 8 |
| Monday, July 17 2006 – 10.30-12.00 |
| How to... design a clinical trial |
| Friedrich K. Port, Ann Arbor, USA |
| Christoph Wanner, Würzburg, Germany |
| top |
| • Free Communication session 17 |
| Sunday, July 16 2006 - 13.45-15.15 |
| Anaemia, erythropoiesis and angiogenesis |
| 6 free communications |
| • Free Communication session 18 |
| Tuesday, July 18 2006 - 11.00-12.30 |
| Kidney injury and repair |
| 6 free communications |
| • Free Communication session 19 |
| Tuesday, July 18 2006 - 11.00-12.30 |
| Vasculitis: new therapeutic perspectives |
| 6 free communications |
| top |
| • Prolonging time on peritoneal dialysis |
| • Commonly encountered disturbances of fluid and electrolyte balance in clinical practice |
| • 2005 ASN Highlights |
| top |
